abatacept
- noun
- /ˌæbəˈteɪsɛpt/
- Specialized
:
abatacept
- An integrated assessment of safety data from five double-blind abatacept clinical trials comprising approximately 2,000 patients has demonstrated that abatacept is generally safe and well tolerated when combined with non-biologic background therapy.
- abatacept versus placebo
- abatacept-treated patients
- safety of abatacept
Examples
-
Serious infections were reported in 3% of patients treated with abatacept and 2% of patients given a placebo.
Academic text (2007) -
Abatacept also slowed the progression of structural damage compared with placebo/MTX alone.
Academic text (2007) -
Safety and tolerability of abatacept in clinical studies.
Academic text (2007) -
In addition to these clinical benefits, a fixed dose of abatacept has demonstrated a consistent safety and tolerability profile.
Academic text (2007) -
Adjunctive abatacept slightly improves physical health and reduces fatigue at the expense of an increased risk of serious adverse effects.
Academic text (2017) -
The most common (<1%) serious infections reported with abatacept were pneumonia, cellulitis, urinary tract infection, bronchitis, diverticulitis, and acute pyelonephritis.
Academic text (2007) -
In clinical trials, abatacept has been effective in reducing symptoms of rheumatoid arthritis.
-
Patients taking abatacept often experience less joint pain and swelling compared to those on standard treatments.
-
The doctor prescribed abatacept to help manage my autoimmune disease more effectively.
Synonyms
1
3.9
A drug that makes the body's immune system weaker to prevent organ rejection or treat autoimmune disease
Drug that makes the body's immune system weaker
Surface Forms
Etymology
Abatacept is a modern drug name; a helpful way to remember it is to see the ending -cept as like 'accept' or 'receive', because the medicine keeps certain immune cells from 'receiving' signals that make them attack the body. That's why abatacept is used to calm the immune system in autoimmune disease.